Ann: Nuheara Receives Ethics Approval To Commence Clinical Trial, page-24

First 24 Last

Share
Profile

Follow
tallplumber

5,014 Posts.

758

15/09/21

17:24

Post #: 56091353
Share

Originally posted by FrankieAlfie ↑

Exactly my point. It's highly speculative. My method for managing risk is to have doubts, provide evidence and then calculate the risk/reward. There is always doubts about any investment. But on this thread, you've got people investing because their main business is up the creek or they are hoping it will turn around. That's just lunacy. Don't invest more than you can afford to lose in the spec end and if you can't afford to lose it don't come on here and whine. Grow a set.
As to the management team, one of the first criteria for investment is looking at the management team. When you originally bought in you obviously ticked off on the management team otherwise why buy?
What we have here is a bunch of people who have either invested too much and are feeling the pressure. Unfortunately, the rest of us have to listen to their complaints because they don't have the backbone to accept responsibility for their own decisions. Others who think management is the problem could well look in the mirror and say when did I develop a world-class product and bring it to market and then get a global giant like HP interested and do it all in the space of 5 years? As for buying on market any investor worth their salt knows that buying on market is extremely difficult for directors due to insider trading laws.
Nobody knows when the traction will occur with the SP. But you can be guaranteed that it will not be a gradual increase but rather a spike. And its just patience needed until then.
Finally, if the people on this site are legitimate investors why would you sabotage your own investment by spreading negative sentiment? Only two reasons, if they are an idiot or if they are trying to push the price lower to purchase more at a cheaper price.
We now know HP is selling the buds as part of their package so maybe these threads might cheer up a little bit.....

Expand

Big call champ....calling some shareholders idiots

NUH Price at posting: 2.9¢ Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

BUX

Buxton projects new graphite province discovery at WA Narryer play

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

There are more pages in this discussion • 39 more messages in this thread...

First 24 Last

Add NUH (ASX) to my watchlist

(20min delay)
Last 8.1¢		Change 0.000(0.00%)		Mkt cap ! $21.91M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

Ann: Nuheara Receives Ethics Approval To Commence Clinical Trial, page-24

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

BCI reaches close of funding facility for salt-first part of Mardie project

Buxton projects new graphite province discovery at WA Narryer play

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Featured News

Featured News

Ann: Nuheara Receives Ethics Approval To Commence Clinical Trial, page-24

Top Stories

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

BCI reaches close of funding facility for salt-first part of Mardie project

Buxton projects new graphite province discovery at WA Narryer play

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Featured News

Featured News